Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy

Background : The impact of the RECIST 1.1 on the selection of target lesions and assessment of tumor response was not evaluated in patients with advanced NSCLC who received cytotoxic chemotherapy. Methods: We reviewed medical records of patients with advanced NSCLC who received first-line chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hyun Chang, Kim, Jung Han, Kim, Hyeong Su, Jung, Soong Goo, Hwang, Sang Muk, Ju, Sung Bae, Yang, Ik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466415/
https://www.ncbi.nlm.nih.gov/pubmed/26078796
http://dx.doi.org/10.7150/jca.11794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466415/
https://www.ncbi.nlm.nih.gov/pubmed/26078796
http://dx.doi.org/10.7150/jca.11794

Ejemplares similares